The 14-3-3? protein appears to contribute to the pathologic process of joint erosion and, as such, is an emerging biomarker of joint damage in rheumatoid arthritis (RA) and psoriatic arthritis. Concentrations are significantly higher in people with active joint disease than in those with inactive RA or psoriasis without arthritis. Measurement of 14-3-3? complements RF and CCP antibody tests and may improve diagnostic sensitivity.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
5 - 10 days
Test sent to Quest Diagnostics Valencia, performed by Quest Diagnostics Nichols Institute San Juan Capistrano